-
Je něco špatně v tomto záznamu ?
p53 limits B cell receptor (BCR) signalling: a new role for miR-34a and FOXP1
K. Cerna, M. Mraz,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu úvodníky
Perzistentní odkaz
https://www.medvik.cz/link/bmc19001424
Online
Plný text
NLK
Free Medical Journals
od 2010
Freely Accessible Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19001424
- 003
- CZ-PrNML
- 005
- 20190115111327.0
- 007
- ta
- 008
- 190107s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.18632/oncotarget.26376 $2 doi
- 035 __
- $a (PubMed)30559925
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Cerna, Katerina $u Molecular Medicine, CEITEC Masaryk University, Brno, Czech Republic; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine MU, Brno, Czech Republic.
- 245 10
- $a p53 limits B cell receptor (BCR) signalling: a new role for miR-34a and FOXP1 / $c K. Cerna, M. Mraz,
- 655 _2
- $a úvodníky $7 D016421
- 700 1_
- $a Mraz, Marek $u Molecular Medicine, CEITEC Masaryk University, Brno, Czech Republic; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine MU, Brno, Czech Republic.
- 773 0_
- $w MED00184852 $t Oncotarget $x 1949-2553 $g Roč. 9, č. 92 (2018), s. 36409-36410
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30559925 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190115111537 $b ABA008
- 999 __
- $a ind $b bmc $g 1364092 $s 1039547
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 9 $c 92 $d 36409-36410 $e 20181123 $i 1949-2553 $m Oncotarget $n Oncotarget $x MED00184852
- LZP __
- $a Pubmed-20190107
